Recombinant human growth hormone in the treatment of C.836A/G-caused short stature in a girl: a case report and literature review.

ABSTRACT:

Background

When we treated the C.836A/G-caused short stature girls with rhGH (recombinant growth hormone) for short stature, the effect of height improvement was good, but in the course of treatment, there was a side effect of leukopenia, which led to the interruption of treatment. We consult the literature, did not find such relevant reports, therefore, the objective of this study is to share the novel treatment method of C.836A/G-caused short stature and report the treatment response and adverse events of the child with C.836A/G-caused short stature.

Case description

The clinical data of 1 child with C.836A/G-caused short stature were collected, and the efficacy of rhGH in the treatment of this child was observed. The female child aged 5 years and 5 months old was treated

SUBMITTER: Qian X 

PROVIDER: S-EPMC9173874 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature